Literature DB >> 33433966

Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.

Viraj V Patel1, Uriel R Felsen2, Molly Fisher3, Melissa J Fazzari4, Mindy S Ginsberg4, Robert Beil1, Matthew J Akiyama1,2, Kathryn Anastos1, David B Hanna4.   

Abstract

BACKGROUND: Limited data exist about clinical outcomes and levels of inflammatory and immune markers among people hospitalized with COVID-19 by HIV serostatus and by HIV viral suppression.
SETTING: Large tertiary care health system in the Bronx, NY, USA.
METHODS: We conducted a retrospective cohort study of 4613 SARS-CoV-2 PCR-positive patients admitted between March 10, 2020, and May 11, 2020. We examined in-hospital intubation, acute kidney injury (AKI), hospitalization length, and in-hospital mortality by HIV serostatus, and by HIV-viral suppression and CD4 counts among people living with HIV (PLWH) using adjusted competing risks regression. We also compared immune and inflammatory marker levels by HIV serostatus and viral suppression.
RESULTS: Most patients were either non-Hispanic Black (36%) or Hispanic (37%); 100/4613 (2.2%) were PLWH, among whom 15 had detectable HIV viral load. PLWH compared to patients without HIV had increased intubation rates (adjusted hazard ratio 1.73 [95% CI: 1.12 to 2.67], P = 0.01). Both groups had similar rates of AKI, length of hospitalization, and death. No (0%) virally unsuppressed PLWH were intubated or died, versus 21/81 (26%, P = 0.04) and 22/81 (27%, P = 0.02) of virally suppressed PLWH, respectively. Among PLWH, higher CD4 T-cell counts were associated with increased intubation rates. C-reactive protein, IL-6, neutrophil counts, and ferritin levels were similar between virally suppressed PLWH and patients without HIV, but significantly lower for unsuppressed PLWH (all P < 0.05).
CONCLUSIONS: PLWH had increased risk of intubation but similarly frequent rates of AKI and in-hospital death as those without HIV. Findings of no intubations or deaths among PLWH with unsuppressed HIV viral load warrant further investigation.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33433966      PMCID: PMC8720497          DOI: 10.1097/QAI.0000000000002578

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

Review 1.  SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.

Authors:  Julia Del Amo; Rosa Polo; Santiago Moreno; Inma Jarrín; Miguel A Hernán
Journal:  AIDS       Date:  2022-02-01       Impact factor: 4.177

Review 2.  High-value laboratory testing for hospitalized COVID-19 patients: a review.

Authors:  Daniela Cihakova; Michael B Streiff; Steven P Menez; Teresa K Chen; Nisha A Gilotra; Erin D Michos; Kieren A Marr; Andrew H Karaba; Matthew L Robinson; Paul W Blair; Maria V Dioverti; Wendy S Post; Andrea L Cox; Annukka A R Antar
Journal:  Future Virol       Date:  2021-09-21       Impact factor: 3.015

Review 3.  SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.

Authors:  Ralf Duerr; Keaton M Crosse; Ana M Valero-Jimenez; Meike Dittmann
Journal:  Microorganisms       Date:  2021-06-27

4.  Risk Factors for Hospitalization in People With HIV and COVID-19.

Authors:  Kevin F Kamis; Lauren Barbera; Mona Abdo; Sarah E Rowan; Cory Hussain; Edward M Gardner; Steven C Johnson; Samantha MaWhinney; Amelia J Davis; Jesse Carlson; Katie A Kozacka; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2021-11-01       Impact factor: 3.771

5.  Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland.

Authors:  Justyna D Kowalska; Martyna Lara; Maria Hlebowicz; Elżbieta Mularska; Elżbieta Jabłonowska; Ewa Siwak; Alicja Wandałowicz; Magdalena Witak-Jędra; Anita Olczak; Monika Bociąga-Jasik; Magdalena Suchacz; Justyna Stempkowska-Rejek; Piotr Wasilewski; Miłosz Parczewski
Journal:  Infection       Date:  2022-07-27       Impact factor: 7.455

Review 6.  Gastrointestinal manifestations of human immunodeficiency virus and coronavirus disease 2019: Understanding the intersecting regions between the two epidemics.

Authors:  Ahmed Cordie; Yasmine Gaber; Mohamed AbdAllah; Alessandra Vergori; Brenda Kharono; Salma Omran; Shimaa Afify; Mehdi Karkouri; Mohamed Chakroun; Sherief Musa; Michelle Moorhouse; Gamal Esmat
Journal:  Arab J Gastroenterol       Date:  2021-05-26       Impact factor: 2.076

7.  Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH.

Authors:  Roberta Gagliardini; Alessandra Vergori; Patrizia Lorenzini; Stefania Cicalini; Carmela Pinnetti; Valentina Mazzotta; Annalisa Mondi; Ilaria Mastrorosa; Marta Camici; Simone Lanini; Marisa Fusto; Jessica Paulicelli; Maria Maddalena Plazzi; Luisa Marchioni; Chiara Agrati; Anna Rosa Garbuglia; Pierluca Piselli; Emanuele Nicastri; Fabrizio Taglietti; Fabrizio Palmieri; Gianpiero D'Offizi; Enrico Girardi; Francesco Vaia; Andrea Antinori
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

8.  COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study.

Authors:  Jing Sun; Rena C Patel; Qulu Zheng; Vithal Madhira; Amy L Olex; Jessica Y Islam; Evan French; Teresa Po-Yu Chiang; Hana Akselrod; Richard Moffitt; G Caleb Alexander; Kathleen M Andersen; Amanda J Vinson; Todd T Brown; Christopher G Chute; Keith A Crandall; Nora Franceschini; Roslyn B Mannon; Gregory D Kirk
Journal:  medRxiv       Date:  2021-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.